Summary
Both peptides fall into a similar broad context as Neuropeptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Epitalon is more often discussed in the realm of Aging and longevity, whereas Setmelanotide is more often associated with the realm of Metabolic and endocrine. Their biological logic is quite different: Epitalon is a signaling modulator and a gene expression modulator, whereas Setmelanotide is a receptor agonist. Epitalon has a more synthetic analog origin, while Setmelanotide is closer to synthetic design background and their development context also differs, with Epitalon approved for Research use only while Setmelanotide is approved. Epitalon takes the form of a linear peptide, whereas Setmelanotide is closer to a cyclic peptide, while Setmelanotide incorporates d-amino acid substitution features that are not part of Epitalon.